Medical Developments International Limited
MDDVF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.38 | -0.37 | -0.00 | -0.05 |
| FCF Yield | 0.79% | -2.02% | -15.16% | -13.22% |
| EV / EBITDA | -37.01 | 10.98 | -1.72 | -4.26 |
| Quality | ||||
| ROIC | 0.90% | 4.36% | -11.54% | -13.86% |
| Gross Margin | 77.13% | 73.64% | 16.34% | -36.15% |
| Cash Conversion Ratio | -3.38 | -2.47 | 0.14 | 0.59 |
| Growth | ||||
| Revenue 3-Year CAGR | 14.73% | 15.48% | 14.69% | 13.26% |
| Free Cash Flow Growth | 146.59% | 84.53% | 27.04% | 35.77% |
| Safety | ||||
| Net Debt / EBITDA | 15.46 | -5.73 | 0.41 | 1.18 |
| Interest Coverage | 0.00 | 0.00 | -92.10 | -295.43 |
| Efficiency | ||||
| Inventory Turnover | 0.46 | 0.76 | 1.72 | 2.16 |
| Cash Conversion Cycle | 96.47 | 66.21 | 38.30 | 27.54 |